BioLife Solutions (NASDAQ: BLFS) reported Q3 EPS of $0.01, $0.02 better than the analyst estimate of ($0.01). Revenue for the quarter came in at $28.07 million versus the consensus estimate of $25.69 million.

GUIDANCE:

BioLife Solutions sees FY2025 revenue of $95-96 million, versus the consensus of $101.3 million.

For earnings history and earnings-related data on BioLife Solutions (BLFS) click here.